Found: 10
Select item for more details and to access through your institution.
Improving outcomes for patients with lymphoma: design and development of the Australian and New Zealand Lymphoma and Related Diseases Registry.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Primary gastric diffuse large B‐cell lymphoma: A multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 534, doi. 10.1111/bjh.19470
- By:
- Publication type:
- Article
The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 1, p. 15, doi. 10.1111/bjh.17404
- By:
- Publication type:
- Article
Evolution of eligibility criteria for diffuse large B‐cell lymphoma randomised controlled trials over 30 years.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 741, doi. 10.1111/bjh.17436
- By:
- Publication type:
- Article
Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B‐acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 123, doi. 10.1111/bjh.16949
- By:
- Publication type:
- Article
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma Alliance.
- Published in:
- Internal Medicine Journal, 2022, v. 52, n. 9, p. 1624, doi. 10.1111/imj.15658
- By:
- Publication type:
- Article
Clinical characteristics of Australian treatment‐naïve patients with classical Hodgkin lymphoma from the lymphoma and related diseases registry.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 386, doi. 10.1111/ejh.13915
- By:
- Publication type:
- Article
Elotuzumab in Combination with Pomalidomide and Corticosteroids for Relapsed or Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e83, doi. 10.1016/j.clml.2017.03.151
- By:
- Publication type:
- Article
Carotid body tumour.
- Published in:
- ANZ Journal of Surgery, 2011, v. 81, n. 12, p. 934, doi. 10.1111/j.1445-2197.2011.05914.x
- By:
- Publication type:
- Article
Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project.
- Published in:
- EJHaem, 2024, v. 5, n. 2, p. 325, doi. 10.1002/jha2.870
- By:
- Publication type:
- Article